People who recover from COVID-19 can develop antibodies to fight off coronavirus infections in the future. Several labs and pharmaceutical companies hope to harness the power of antibodies in a drug that could help treat and prevent COVID-19 in the general population.
Here & Now’s Tonya Mosley speaks with Leonard Schleifer, president and CEO of Regeneron Pharmaceuticals, a drug company that is preparing to test one such treatment in humans.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org.